Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study for cats. MEOW-1, as the study is called, will look to use OKV-119, a ...

Around 70% of Americans are obese or overweight. And their cats aren’t too far off. According to the Association for Pet ...

The device, OKV-119, is a GLP-1 implant, or a small device inserted under the skin that can deliver doses of medication for ...

“Caloric restriction, or fasting, is one of the most well-established interventions for extending lifespan and improving ...

San Francisco-based pharmaceutical company OKAVA is investigating an implant that slowly releases a GLP-1 medication for up ...

Some experts cited the case of Slentrol, an older weight loss drug for dogs made by Pfizer’s animal health division (which ...

Up to 50 cats are expected to participate in the trial, with their weight and health metrics monitored at three and six ...

A clinical study into weight loss drugs for pets just launched, with results from the trial expected by next summer.

The world's first GLP-1 weight-loss treatment for pets has begun with successful cat dosing. The six-month implant could ...

The 50 cats in MEOW-1 will be given an implant smaller than a microchip. Some cats will receive a placebo, while others will ...

A pharmaceutical company has begun testing the first GLP-1 weight-loss therapy designed specifically for cats. The implant, ...